Veterinary Medicines

Suvaxyn Parvo–E Amphigen

Authorised
  • Porcine parvovirus, strain S-80, Inactivated
  • Erysipelothrix rhusiopathiae, serotype 2, Inactivated
Download as PDF

Product identification

Medicine name:
Suvaxyn Parvo–E Amphigen
Suvaxyn Parvo/E-Amphigen vakcina A.U.V.
Active substance:
  • Porcine parvovirus, strain S-80, Inactivated
  • Erysipelothrix rhusiopathiae, serotype 2, Inactivated
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Porcine parvovirus, strain S-80, Inactivated
    94.10
    haemagglutination inhibiting unit(s)
    /
    2.00
    millilitre(s)
  • Erysipelothrix rhusiopathiae, serotype 2, Inactivated
    13.50
    relative potency
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AL01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Package description:
  • box containing 1 vial of 50 ml (25 doses)
  • box containing 1 vial of 20 ml (10 doses)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Hungary Kft.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Manufacturing & Research Spain S.L.
  • VMD
  • PEI
Responsible authority:
  • National Food Chain Safety Office
Authorisation number:
  • 3841/X/17 NÉBIH ÁTI
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0266/001
Concerned member states:
  • Austria
  • Bulgaria
  • Croatia
  • Cyprus
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Latvia
  • Lithuania
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovenia
  • Sweden
  • United Kingdom (Northern Ireland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."